Catherine L Cherry Selected Research

Stavudine (Zerit)

12/2020	Brief Report: Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without Stavudine.
4/2011	HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
8/2010	Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients.
4/2010	Ubisol-Aqua: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model.
10/2008	Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?
2/2008	Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk.
3/2005	Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.
1/2005	Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine L Cherry Research Topics

Disease

4	Peripheral Nervous System Diseases (PNS Diseases) 12/2020 - 08/2008
3	Acquired Immunodeficiency Syndrome (AIDS) 12/2020 - 10/2008
3	Pain (Aches) 09/2015 - 12/2010
3	Infections 10/2011 - 05/2006
2	HIV Infections (HIV Infection) 01/2018 - 06/2012
2	Disease Progression 01/2018 - 05/2006
2	Inflammation (Inflammations) 01/2011 - 02/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2010 - 01/2005
1	Frailty 08/2017
1	Neuralgia (Stump Neuralgia) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2014
1	Diabetes Mellitus 06/2012
1	Malnutrition (Nutritional Deficiencies) 06/2012
1	Immune Reconstitution Inflammatory Syndrome 01/2011
1	Drug-Related Side Effects and Adverse Reactions 05/2009
1	Viremia 08/2008
1	Polyneuropathies (Polyneuropathy) 02/2008
1	Lipodystrophy 03/2005
1	Hyperlactatemia 01/2005

Drug/Important Bio-Agent (IBA)

8	Stavudine (Zerit)FDA LinkGeneric 12/2020 - 01/2005
4	NucleosidesIBA 04/2010 - 01/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2017
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 10/2011 - 08/2010
2	Didanosine (Videx)FDA LinkGeneric 04/2010 - 02/2008
1	G(M3) GangliosideIBA 08/2017
1	phosphatidylethanolamineIBA 08/2017
1	Triglycerides (Triacylglycerol)IBA 08/2017
1	ceramide monohexosideIBA 08/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 09/2015
1	Macrophage Migration-Inhibitory FactorsIBA 07/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 06/2012
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 05/2012
1	ChemokinesIBA 01/2011
1	Enfuvirtide (Fuzeon)FDA Link 08/2008
1	Zalcitabine (Hivid)FDA Link 02/2008
1	CytokinesIBA 02/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2006
1	Reverse Transcriptase InhibitorsIBA 05/2006
1	abacavir (Ziagen)FDA Link 01/2005
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2005
1	Mitochondrial DNA (mtDNA)IBA 01/2005

Therapy/Procedure

4	Therapeutics 08/2017 - 08/2010
3	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 01/2005
2	Art Therapy 01/2011 - 12/2010
1	Lasers (Laser) 10/2011
1	Ligation 05/2009